Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Infants who appear to have symptoms of MEHMO syndrome and are at least 1 week old, or family members without symptoms who are at least 1 month old
- People who show signs or symptoms that suggest MEHMO syndrome, where genetic testing has either not been done or has given unclear results (for the screening part of the study)
- Relatives of someone with MEHMO syndrome or a related condition, where their genetic information could be useful for research (for the screening part of the study)
- People who show signs or symptoms of MEHMO syndrome and whose genetic testing has found a relevant change or unclear finding in one of the genes linked to this condition (for the main study)
- Relatives of someone with MEHMO syndrome or a related condition who carry the specific genetic change associated with that condition (for the main study)
- Family members who do not have the condition and do not carry the relevant genetic change, but have a family member with MEHMO syndrome or a related condition (for the main study)
Who may not be able to join:
- People who, in the view of the research team, would be unable to follow the study requirements
- People who have other medical conditions that the research team believes could put them at greater risk by taking part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: An N Dang Do, M.D., Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phone: (301) 496-8849
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Characterize the presentation of MEHMO syndrome and eIF2-pathway related conditions.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.